semaglutide canada patent expiry Sandoz sees unbranded versions of Ozempic launching in by end-June 2026 Ozempic's Patent Protection Starts to

Both work, but the pathway you choose determines what happens when you stop

On average, clinical trials have found that patients on semaglutide (the active ingredient in Ozempic and Wegovy) may lose between 15% to 20% of their body weight within the first year of use

Higher concentrations mean smaller injection volumes, which generally means less discomfort

Our team will confirm whether your plan provides this coverage and will advocate on your behalf, ensuring a seamless experience from prescription to medication delivery

Whatever medication you are on, talk with your prescriber before drinking, and seek medical care for any severe stomach pain, persistent vomiting, or symptoms of very low blood sugar

When will I notice improvements in blood sugar control